Editorial Commentary:Learning from Our Failures: The Antifungal Treatment Conundrum
Open Access
- 1 May 2008
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 46 (9) , 1434-1435
- https://doi.org/10.1086/587102
Abstract
It is often said that we learn more from our failures than from our successes. Certainly, there is truth to this adage with regard to antifungal therapy. There is much for us to learn from antifungal treatment failure.Keywords
This publication has 7 references indexed in Scilit:
- When Primary Antifungal Therapy FailsClinical Infectious Diseases, 2008
- Serum Aspergillus galactomannan antigen values strongly correlate with outcome of invasive aspergillosisCancer, 2007
- Immune reconstitution inflammatory syndrome in cancer patients with pulmonary aspergillosis recovering from neutropenia: Proof of principle, description, and clinical and research implicationsCancer, 2007
- The Poor Prognosis of Central Nervous System Cryptococcosis among Nonimmunosuppressed Patients: A Call for Better Disease Recognition and Evaluation of Adjuncts to Antifungal TherapyClinical Infectious Diseases, 2006
- Invasive pulmonary aspergillosis transformed into fatal mucous impaction by immune reconstitution in an AIDS patientEuropean Journal of Clinical Microbiology & Infectious Diseases, 2005
- An Immune Reconstitution Syndrome-Like Illness Associated withCryptococcus neoformans Infection in Organ Transplant RecipientsClinical Infectious Diseases, 2005
- The Role of Immune Reconstitution Inflammatory Syndrome in AIDS‐RelatedCryptococcus neoformansDisease in the Era of Highly Active Antiretroviral TherapyClinical Infectious Diseases, 2005